Editas Medicine (EDIT) Current Assets (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Current Assets data on file, last reported at $163.9 million in Q4 2025.

• On a quarterly basis, Current Assets fell 43.35% year-over-year to $163.9 million in Q4 2025; TTM through Dec 2025 was $163.9 million, a 43.35% decrease from a year earlier, with the FY2025 full-year figure at $163.9 million, down 43.35% from the prior year.
• Current Assets for Q4 2025 stood at $163.9 million, down from $176.9 million in the prior quarter.
• Over the last five years, Current Assets for EDIT reached as high as $632.3 million in Q1 2021 and fell as low as $163.9 million in Q4 2025.
• Historically, Current Assets has averaged $371.5 million across 5 years, with a median of $348.8 million in 2022.
• Across the five-year window, Current Assets surged 48.74% in 2021 and slumped 43.35% in 2025, its largest moves.
• Year by year, Current Assets stood at $507.3 million in 2021, then declined by 29.68% to $356.8 million in 2022, then dropped by 4.46% to $340.8 million in 2023, then retreated by 15.11% to $289.3 million in 2024, then slumped by 43.35% to $163.9 million in 2025.
• Per Business Quant data, the three most recent Current Assets figures were $163.9 million in Q4 2025, $176.9 million in Q3 2025, and $182.8 million in Q2 2025.